Cullinan Therapeutics (CGEM) Return on Sales (2021)

Historic Return on Sales for Cullinan Therapeutics (CGEM) over the last 1 years, with Q4 2021 value amounting to 3.56%.

  • Cullinan Therapeutics' Return on Sales changed N/A to 3.56% in Q4 2021 from the same period last year, while for Dec 2021 it was 3.56%, marking a year-over-year change of. This contributed to the annual value of 3.56% for FY2021, which is N/A changed from last year.
  • Latest data reveals that Cullinan Therapeutics reported Return on Sales of 3.56% as of Q4 2021.
  • In the past 5 years, Cullinan Therapeutics' Return on Sales ranged from a high of 0.07% in Q1 2021 and a low of 3.56% during Q4 2021